Skip to content

Dr. Ella Ver Donck

Active
Private limited companyfounded 2007active for 19 yearsMontgomerylaan 2, 8300 Knokke-Heist, BelgiumKBO/BCE: BE 0888.976.591
Summary

Dr. Ella Ver Donck has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €856,456 and a net result of €243,492. Equity has been growing by about 15% per year since 2018. Its solvency ranks better than 86% of 617 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 24-04-2007 Normal situation
Activity
Research and development on biotechnology NACE 72101and 1 other
Establishment unit
2.188.014.053 8300 Knokke-Heist, since 24-04-2007
Financial year end
31 December
Peppol
Reachable since 24-11-2025

Board and ownership

Board
  • Ver Donck EllaDirector

Financial position

96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€326,967
▼ 10.4%
Turnover
≈ €650,000
estimated
Profit
€243,492
▼ 10.0%
Equity
€856,456
▲ 0.4%
Total assets
€931,788
▲ 0.6%
Score breakdownlowers riskSize: total assets €931,788Figures for financial year 2025 (filed on 17-07-2026)Equity €856,456 (91.9% of total assets)Founded in 2007Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 69% of micro companies in research and development (NACE 72)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 91.9% of total assets
Liquidity 63+8
short-term debt 8.1% · cash 10.4%
Profitability 100=
return on assets 26.1%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (935 companies, NACE 72, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: 0.1%▲ +0.1 percentage points vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025highest value 08-2025: < 0.1%▼ -0.1 percentage points vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: 0.1%▲ +0.1 percentage points vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: < 0.1%▼ -0.1 percentage points vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value
Credit of up to €80,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 11.85 (12.17 in 2024), above the usual 1.5. Short-term debt is 8.1% and cash 10.4% of total assets. 8.1% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro). It does better than 83% of them on solvency, 53% on liquidity, 90% on profitability and 48% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Size: total assets €931,788
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 17-07-2026)
NBB · annual accounts
lowers risk · Equity €856,456 (91.9% of total assets)
NBB · annual accounts
lowers risk · Founded in 2007
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 17-07-2026, 14 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
14 days early
2024
9 days early
2023
30 days late
2022
on the day
2021
2 days early
2020
30 days late
2019
32 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 10 days after the deadline. In the sector (NACE 72), the median for financial year 2024 was 13 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 July (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher net result than 94% of companies in research and developmentsector median €27,193 · 617 companies €243,492 View
  • Positive: 8 profitable years in a rowprofit 2025: €243,492 8 years View

Recent changes

  1. · Gazette deed Incorporation
All 14 events

Comparable companies

These companies have the same main activity as Dr. Ella Ver Donck: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €808,000 and €1.5m, founded between 2006 and 2008.

CompanyTotal assetsGross margin
Dr. Ella Ver Donck Knokke-Heist€0.9m€0.3m
DOKTER MARC DE JAEGER Lochristi€0.9m€0.2m
Dokter Bernard Kint Antwerpen€1.1m€0.2m
Marco Guidi, geneesheer Dendermonde€1.0m€0.2m
NYEMB Tournai€1.2m€0.2m
Dr. Naessens Benedicte Laarne€0.8m€0.2m
DR. VERSTRAETE – DR. RYCKAERT Knokke-Heist€1.5m€0.5m
Full comparison

Key facts about Dr. Ella Ver Donck

What is the company number of Dr. Ella Ver Donck?
The company number of Dr. Ella Ver Donck is 0888.976.591. The VAT number is the same number with BE in front: BE 0888.976.591.
Where is Dr. Ella Ver Donck based?
The registered office is at Montgomerylaan 2, 8300 Knokke-Heist.Company details
What does Dr. Ella Ver Donck do?
According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
What is the legal form of Dr. Ella Ver Donck?
The legal form of Dr. Ella Ver Donck is Private limited company (BV).
When was Dr. Ella Ver Donck founded?
Dr. Ella Ver Donck was founded on 24-04-2007.
Is Dr. Ella Ver Donck still active?
Yes, Dr. Ella Ver Donck is an active enterprise in the KBO register.
What is the turnover of Dr. Ella Ver Donck?
The turnover in financial year 2025 is ≈ €650,000. This figure is estimated from the gross margin of €326,967 and 883 comparable companies of the same size. It probably lies between €460,000 and €950,000. It is a rough estimate.Financials
Is Dr. Ella Ver Donck profitable?
In financial year 2025, Dr. Ella Ver Donck made a profit of €243,492.
Where can I find the annual accounts of Dr. Ella Ver Donck?
Dr. Ella Ver Donck filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Ella Ver Donck due?
Dr. Ella Ver Donck must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.